These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6173450)

  • 1. [Effects of inosiplex on viral growth and experimental viral infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):490-500. PubMed ID: 6173450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effects of inosiplex in viral infections. The activity of inosiplex and its constituents (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Aug; 55(8):541-50. PubMed ID: 6173451
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effects of inosiplex in viral infections. Comparison with other immunostimulants (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Aug; 55(8):551-7. PubMed ID: 6173452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of inosiplex on host defense against infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):479-89. PubMed ID: 6173449
    [No Abstract]   [Full Text] [Related]  

  • 6. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T; Glasky AJ
    Ann N Y Acad Sci; 1977 Mar; 284():128-38. PubMed ID: 81634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Virus diseases treated with isoprinosine and ribavirin (author's transl)].
    Propper P; Kopecký J
    Cas Lek Cesk; 1982 Jan; 121(1):22-4. PubMed ID: 6173129
    [No Abstract]   [Full Text] [Related]  

  • 8. Levamisole and inosiplex: antiviral agents with immunopotentiating action.
    Hadden JW; Lopez C; O'Reilly RJ; Hadden EM
    Ann N Y Acad Sci; 1977 Mar; 284():139-52. PubMed ID: 81635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of rabies virus in tissue culture].
    Hernández Jáuregui-Alvarez P
    Gac Med Mex; 1982 Sep; 118(9):379-88. PubMed ID: 6186562
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Inosiplex on BHK cells "in vitro".
    González-Diddi M; Rangel-Gutiérrez N; Tellez-Martínez J; Lonngi-Villanueva G; Hernández-Jauregui P
    Arch Invest Med (Mex); 1980; 11(2):249-65. PubMed ID: 6158923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isoprinosine].
    Vâţă A
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(3):507-9. PubMed ID: 6189169
    [No Abstract]   [Full Text] [Related]  

  • 12. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Campoli-Richards DM; Sorkin EM; Heel RC
    Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin and inosiplex: a review of their present status in viral diseases.
    Chang TW; Heel RC
    Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Morita Y; Mochizuki H; Suzuki Y
    Infect Immun; 1982 Oct; 38(1):243-50. PubMed ID: 6183209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprinosine: an overview.
    Simon LN; Glasky AJ
    Cancer Treat Rep; 1978 Nov; 62(11):1963-9. PubMed ID: 83189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory activity of isoprinosine on experimental viral infections in avian models.
    Moya P; Alonso ML; Baixeras E; Ronda E
    Int J Immunopharmacol; 1984; 6(4):339-43. PubMed ID: 6207123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers].
    Tazulakhova EB; Amitina NN; Ershov FI
    Biull Eksp Biol Med; 1985 Oct; 100(10):457-9. PubMed ID: 2413924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.
    Bradshaw LJ; Sumner HL
    Ann N Y Acad Sci; 1977 Mar; 284():190-6. PubMed ID: 81637
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
    Schmutzler W; Neukirch B; Ziesche R
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.